[Hemodynamic evaluation of nifedipine in primary pulmonary hypertension--short and long term effects].
1986
S Yamaguchi, and
K Tsuiki, and
M Hayasaka, and
M Oguma, and
I Ohta, and
T Kaminishi, and
H Sukekawa, and
T Kanaya, and
S Yasui
UI
MeSH Term
Description
Entries
D006976
Hypertension, Pulmonary
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
Pulmonary Hypertension
D008875
Middle Aged
An adult aged 45 - 64 years.
Middle Age
D009543
Nifedipine
A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D005260
Female
Females
D006439
Hemodynamics
The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.
Hemodynamic
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328
Adult
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
Adults
Related Publications
S Yamaguchi, and
K Tsuiki, and
M Hayasaka, and
M Oguma, and
I Ohta, and
T Kaminishi, and
H Sukekawa, and
T Kanaya, and
S Yasui